Clinical events in a long‐term prospective neonatal cohort of children with sickle cell disease: Evidence for a high disease burden without systematic preventive intensification with hydroxyurea-Reference-Cited by-同舟云学术

Clinical events in a long‐term prospective neonatal cohort of children with sickle cell disease: Evidence for a high disease burden without systematic preventive intensification with hydroxyurea

Published:2023-10-26 Issue:12 Volume:98 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Soulié Alizée¹^ORCID,Kamdem Annie¹,Neumann Florent²,Hau Isabelle¹³,Madhi Fouad¹³,Delestrain Céline¹⁴^ORCID,Shum Mickaël¹⁴,Carlier‐Gonod Adèle¹,Malterre Aline¹,Lezeau Harry⁵,Khazem Bassem⁶,Belozertseva Ekaterina¹^ORCID,Guémas Eric⁷,Epaud Ralph¹⁴^ORCID,Pissard Serge⁸,Arnaud Cécile¹,Pondarré Corinne¹⁹

Affiliation:

1. Pediatric Department, Sickle Cell Disease Referral Center Centre Hospitalier Intercommunal de Créteil Créteil France

2. Pediatric Department Dijon University Hospital Dijon France

3. Paris XII University, IMRB‐GRC GEMINI Créteil France

4. Paris XII University, INSERM, IMRB Créteil France

5. Pediatric Surgery Department Centre Hospitalier Intercommunal de Créteil Créteil France

6. Laboratory of Hematology Centre Hospitalier Intercommunal de Créteil Créteil France

7. BIOSSEC Clinical Biostatistics Paris France

8. Genetics Department Groupe Hospitalo‐Universitaire Henri Mondor, INSERM U955, IMRB, Team 2, Paris XII University Créteil France

9. INSERM U955, IMRB, Paris XII University Créteil France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27142

Reference6 articles.

1. Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France

2. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London

3. Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study

4. Prevalence and risk factors for albuminuria and glomerular hyperfiltration in a large cohort of children with sickle cell anemia

5. Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa